WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (OTCQB:CVRS), a leading developer of precision vascular robotics, announced today that it has initiated a clinical trial of its CorPath System in peripheral vascular interventions. The study is currently enrolling patients at the Medical University of Graz in Graz, Austria, and is led by Prof. Dr. Marianne Brodmann, MD, a leading researcher within the university’s Division of Angiology, in combination with Prof. Dr. Hannes Deutschmann, of the Medical University of Graz Department of Radiology, and study chairman, Dr. Ehtisham Mahmud, director, Sulpizio Cardiovascular Center-Medicine, UC San Diego.
Help employers find you! Check out all the jobs and post your resume.
